Latest Osteoporosis Stories
The European trauma fixation devices report defines and segments the concerned market in Europe with analysis and forecast of revenue.
The North American orthobiologics report defines and segments the concerned market in North America with analysis and forecast of revenue.
Minivelle now approved for prevention of postmenopausal osteoporosis at all doses MIAMI and NEW YORK, Sept. 24, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc.
Data Presented at the American Society of Bone and Mineral Research 2014 Annual Meeting THOUSAND OAKS, Calif., Sept.
Romosozumab Currently in Phase 3 Clinical Development, Pivotal Data Expected in 2016 THOUSAND OAKS, Calif. and BRUSSELS, Sept.
Data Include Eight Year Analyses of Bone Mineral Density Results for Prolia® (Denosumab) and Further Evidence for Significant Bone-Building With Romosozumab THOUSAND OAKS, Calif., Sept.
Adoption of Premium-Priced Vertebral Augmentation Will Drive Market Growth, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept.
Transparency Market Research published a new report "Minimally Invasive Vertebral Compression Fracture Repair Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013
September is National Menopause Awareness Month which is aimed at helping women to understand and embrace menopause in lieu of suffering from its symptoms.
Osteoporosis International is a peer-reviewed medical journal published monthly by Springer Science+Business Media. It was established in 1990. It is the official journal of the International Osteoporosis Foundation and the National Osteoporosis Foundation. The journal includes original research on all areas of osteoporosis and related fields. It also publishes reviews, educational articles, and case reports. Editors-in-chief are R. Lindsay and J.A. Kanis. According to the Journal...
- The act of sweetening by admixture of some saccharine substance.